About FDA

Resources for Cancer Patients and Advocates

FDA offers a variety of resources for patients and the public, including the following:

Further information can be found in the For Patients section of FDA.gov. In addition, FDA's Patient Affairs Staff in the Office of Medical Products and Tobacco (OMPT) is responsible for the coordination of agency-wide and cross-center projects related to patient engagement. Contact: PatientAffairs@fda.hhs.gov

Patient Engagement and Representation:

Patient Engagement Collaborative (PEC): The Patient Engagement Collaborative (PEC) will provide an ongoing forum to discuss how to achieve more meaningful patient engagement in medical product development and other regulatory discussions. For more information, read an FDA Voice blog post about the PEC. Contact: PatientEngagementCollaborative@fda.hhs.gov

Patient Engagement Advisory Committee (PEAC): The Committee provides advice to the Commissioner or designee, on complex issues relating to medical devices, the regulation of devices, and their use by patients. Contact: Letise.Williams@fda.hhs.gov

FDA Patient Representative Program: The FDA Patient Representative Program is managed by the Advisory Committee Oversight and Management Staff (ACOMS) within the Office of the Commissioner. ACOMS coordinates the recruitment, training, and management of FDA Patient Representative Program consultants, who are patients or primary caregivers.

Medical and Drug Information:

Additional Educational Information about Cancer:

Oncology Center of Excellence Contact Information:

Email: FDAOncology@fda.hhs.gov
Twitter: @FDAOncologydisclaimer icon
Website: www.fda.gov/oce


 

Page Last Updated: 11/09/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English